---
title: "NP49425 Generic and Biosimilar Transition Medicines"
ocid: "ocds-h6vhtk-0581ea"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0581ea"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0581ea.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0581ea.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2026-03-30"
---

# NP49425 Generic and Biosimilar Transition Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-h6vhtk-0581ea

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0581ea)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0581ea.json)

## Summary

The procurement process for NP49425 Generic and Biosimilar Transition Medicines is spearheaded by The Common Services Agency, famously known as NHS National Services Scotland (NSS), based in Edinburgh, UK. The tender process has recently reached the contract update stage, with the awarded contract being active as of 18 December 2025. This procurement covers the broad category of pharmaceutical products, with a focus on medicines for NHS Scotland. The goods are delivered across the UKM region, and the contract pertains to various lots including cytokine modulators, cardiovascular and respiratory medicines, and cancer medicines. Notably, the framework agreement spans a potential duration of 48 months, inclusive of possible extensions. The procurement method employed is the open procedure, ensuring a competitive process adhering to the Public Contracts (Scotland) Regulations 2015.

This tender offers substantial growth opportunities, particularly for businesses that specialise in pharmaceuticals, generic medicines, and biotechnology. Companies with established supply chains and those able to meet stringent technical specifications, such as the possession of a UK Marketing Authorisation and ISO 9001 certification, are well-positioned to compete. Additionally, firms with a strategic focus on addressing the climate change emergency through carbon emission reduction plans can leverage this framework to establish strong partnerships with NHS Scotland. The multi-supplier framework agreement encourages a diverse range of participants, extending chances for both large and medium-sized pharmaceutical companies to collaborate and successfully supply a vast array of medicines vital to public health.

## Notice

Supply of generic and biosimilar transition medicines to NHS Scotland.

### Lot Information

Cancer Medicines (Group 1)

Supply of cancer medicines (group 1) to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)

Supply of generic cand biosimilar transition medicines to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-five (35) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cytokine Modulators (Omalizumab)

Supply of cytokine modulators (omalizumab) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-five (35) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines

Supply of gastrointestinal, endocrine, blood, and multiple sclerosis medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty (30) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Denosumab (Osteoporosis) and Ferric Carboxymaltose

Supply of denosumab (osteoporosis) and ferric carboxymaltose to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty (30) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Apremilast

Supply of apremilast to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-seven (27) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cardiovascular and Respiratory Medicines

Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Nintedanib

Supply of nintedanib to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cancer Medicines (Group 2)

Supply of cancer medicines (group 2) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Psychiatry and Neurology Medicines

Supply of psychiatry and neurology medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of seventeen (17) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/029168-2026 |
| Notice type | Planning Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Planning, Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 30 Mar 2026 |
| Submission deadline | 22 Sep 2025 |
| Future notice date | 14 Aug 2025 |
| Award date | 18 Dec 2025 |
| Contract period | 1 Feb 2026 - 30 Sep 2028 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £234,969,011 |
| Lots value | £234,969,011 |
| Awards value | Not specified |
| Contracts value | £128,207,480 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 37 |
| Supplier names | ACCORD HEALTHCARE; AMAROX; AMGEN; AOP ORPHAN; BIOCON PHARMA; BROWN AND BURK; CELIX PHARMA; CELLTRION HEALTHCARE UNITED KINGDOM; CHIESI; CST PHARMA; DR FALK PHARMA; DR REDDY'S LABORATORIES (UK; FERRING PHARMACEUTICALS; FRESENIUS KABI; GEDEON RICHTER; GLENMARK PHARMACEUTICALS EUROPE; JANSSEN-CILAG; LUPIN HEALTHCARE; MERCURY PHARMA GROUP; MERCURY PHARMACEUTICALS; MSN LABS; PERENNIAL PHARMA; PFIZER; ROCHE PRODUCTS; SAMSUNG BIOEPIS; SANDOZ; SERB; STADA UK - THORNTON & ROSS; TAKEDA; TEVA; THERAMEX HQ; VIATRIS UK HEALTHCARE; VIFOR PHARMA; WOCKHARDT; ZENTIVA; ZENTIVA PHARMA; ZYDUS PHARMACEUTICALS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 30 Mar 2026 at 13:46 - AwardUpdate - Award Notice - https://www.find-tender.service.gov.uk/Notice/029168-2026
- 19 Dec 2025 at 16:55 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/085133-2025
- 4 Sep 2025 at 16:01 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/054079-2025
- 21 Aug 2025 at 09:55 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/050443-2025
- 5 Aug 2025 at 15:26 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/046278-2025

## Notice URLs

- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000801883
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000807501
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000819178
- https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0581ea. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0581ea.json.